These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 18358571

  • 1. Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps.
    German N, Wei P, Kaatz GW, Kerns RJ.
    Eur J Med Chem; 2008 Nov; 43(11):2453-63. PubMed ID: 18358571
    [Abstract] [Full Text] [Related]

  • 2. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A.
    J Med Chem; 2008 Jul 24; 51(14):4321-30. PubMed ID: 18578473
    [Abstract] [Full Text] [Related]

  • 3. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N, Tambat R, Chandal N, Verma DK, Thakur KG, Nandanwar H.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0095121. PubMed ID: 34908453
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V.
    Pathol Biol (Paris); 2004 Dec 22; 52(10):607-16. PubMed ID: 15596311
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S, Huth A, Kalbacher H, Kern WV.
    Int J Antimicrob Agents; 2009 Feb 22; 33(2):174-6. PubMed ID: 18945595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bacterial efflux pump inhibition.
    Kaatz GW.
    Curr Opin Investig Drugs; 2005 Feb 22; 6(2):191-8. PubMed ID: 15751743
    [Abstract] [Full Text] [Related]

  • 12. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Sangwan PL, Koul JL, Koul S, Reddy MV, Thota N, Khan IA, Kumar A, Kalia NP, Qazi GN.
    Bioorg Med Chem; 2008 Nov 15; 16(22):9847-57. PubMed ID: 18848780
    [Abstract] [Full Text] [Related]

  • 13. Citral derived amides as potent bacterial NorA efflux pump inhibitors.
    Thota N, Koul S, Reddy MV, Sangwan PL, Khan IA, Kumar A, Raja AF, Andotra SS, Qazi GN.
    Bioorg Med Chem; 2008 Jul 01; 16(13):6535-43. PubMed ID: 18524600
    [Abstract] [Full Text] [Related]

  • 14. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F, Héquet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S.
    Eur J Med Chem; 2015 May 05; 95():185-98. PubMed ID: 25817769
    [Abstract] [Full Text] [Related]

  • 15. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
    Doléans-Jordheim A, Michalet S, Bergeron E, Boisset S, Souard F, Dumontet C, Dijoux-Franca MG, Freney J.
    Ann Biol Clin (Paris); 2008 May 05; 66(5):499-508. PubMed ID: 18957338
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance.
    Kaatz GW.
    Expert Opin Emerg Drugs; 2002 Oct 05; 7(2):223-33. PubMed ID: 15989546
    [Abstract] [Full Text] [Related]

  • 17. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S, Gosetto F, Manfroni G, Tabarrini O, Kaatz GW, Patel D, Cecchetti V.
    J Med Chem; 2011 Aug 25; 54(16):5722-36. PubMed ID: 21751791
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Fournier Dit Chabert J, Marquez B, Neville L, Joucla L, Broussous S, Bouhours P, David E, Pellet-Rostaing S, Marquet B, Moreau N, Lemaire M.
    Bioorg Med Chem; 2007 Jul 01; 15(13):4482-97. PubMed ID: 17498961
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity.
    Franchini C, Muraglia M, Corbo F, Florio MA, Di Mola A, Rosato A, Matucci R, Nesi M, van Bambeke F, Vitali C.
    Arch Pharm (Weinheim); 2009 Oct 01; 342(10):605-13. PubMed ID: 19753564
    [Abstract] [Full Text] [Related]

  • 20. Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus.
    Kerns RJ, Rybak MJ, Kaatz GW, Vaka F, Cha R, Grucz RG, Diwadkar VU, Ward TD.
    Bioorg Med Chem Lett; 2003 May 19; 13(10):1745-9. PubMed ID: 12729656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.